Chronotherapy in hypertension: A pill at night makes things right?

Journal of the American Society of Nephrology

Volumn 22, Issue 12, 2011, Pages 2152-2155

  Orías, Marcelo ^a   Correa Rotter, Ricardo ^b  

^a Sanatorio Allende   (Argentina)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CHRONOTHERAPY; EDITORIAL; ETHNIC AND RACIAL GROUPS; HUMAN; HYPERTENSION; NIGHT; PILL; PRIORITY JOURNAL; SLEEP;

EID: 82655173701     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011101012     Document Type: Editorial

References (16)

1. Koopman M, Koomen G, Krediet R, de Moor E, Hoek F, Arisz L: Circadian rhythm of glomerular filtration rate in normal individuals. Clin Sci 77: 105-111, 1989 (Pubitemid 19154032)
2. Stow LR, Gumz ML: The circadian clock in the kidney. J Am Soc Nephrol 22: 598-604, 2011
3. Bartter F, Delea C, Baker W, Halberg F, Lee J: Chronobiology in the diagnosis and treatment of mesor-hypertension. Chronobiologia 3: 199-213, 1976
4. Kawano Y, Horio T, Matayoshi T, Kamide K: Masked hypertension: Subtypes and target organ damage. Clin Exp Hypertension 30: 289-296, 2008 (Pubitemid 351556174)
5. Hermida RC, Ayala DE, Mojon A, Fernandez JR: Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol 58: 1165-1173, 2011
6. Hermida RC, Ayala DE, Mojon A, Fernandez JR: Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34: 1270-1276, 2011
7. Hermida RC, Diana E. Ayala DE, Mojón A, Fernández, JR: Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol 22: 2313-2321, 2011
8. Jalal DI, Smits G, Johnson RJ, Chonchol M: Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 21: 1543-1549, 2010
9. Lewis JB: Blood pressure control in chronic kidney disease: Is less really more? J Am Soc Nephrol 21: 1086-1092, 2010
10. Hermida RC, Ayala DE, Mojon A, Fernandez JR: Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int 27: 1629-1651, 2010
11. Yusuf S, Sleight, P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342: 145-153, 2000 (Pubitemid 30051645)
12. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350: 757-764, 1997 (Pubitemid 27387202)
13. Upadhyay A, Hwang SJ, Mitchell GF, Vasan RS, Vita JA, Stantchev PI, Meigs JB, Larson MG, Levy D, Benjamin EJ, Fox CS: Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol 20: 2044-2053, 2009
14. Westenfeld R, Schafer C, Kruger T, Haarmann C, Schurgers LJ, Reutelingsperger C, Ivanovski O, Drueke T, Massy ZA, Ketteler M, Floege J, Jahnen-Dechent W: Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol 20: 1264-1274, 2009
15. Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B: Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 21: 137-144, 2010
16. Briet M, Collin C, Karras A, Laurent S, Bozec E, Jacquot C, Stengel B, Houillier P, Froissart M, Boutouyrie P: Arterial remodeling associates with CKD progression. J Am Soc Nephrol 22: 967-974, 2011